Loading clinical trials...
Loading clinical trials...
Donors with favorable KIR B haplotype gene content have yielded reduced relapse risk and improved leukemia free survival (LFS) in retrospective analyses of unrelated donor (URD) hematopoietic cell tra...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
NCT06656494 · Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS)
NCT06859424 · AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), and more
NCT07347171 · Leukemia, AML, and more
NCT07254312 · AML (Acute Myelogenous Leukemia
NCT02143830 · Fanconi Anemia, Severe Marrow Failure, and more
Mayo Clinic - Scottsdale
Scottsdale, Arizona
Colorado Blood Cancer Institute
Denver, Colorado
Emory University
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions